Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 19,794 results that match your search.19,794 results
  • There have been nearly $70 billion worth of deals in the pharmaceutical industry in 2008, almost double the value of last year. Eklavya Gupte investigates the reasons why there is so much activity and finds out how IP is driving the deals
  • As a bilingual country, Canada presents special opportunities and hazards to trade mark owners. Monique Couture explains how a new test has been developed by the courts to judge confusion
  • The European Commission has issued its position paper on pan-European Union IP rights post-Brexit. As patents are not governed by the EU but come under the remit of European Patent Office, they are unaffected by Brexit and are not included in the document. Thus the EU need only concern itself with other IP rights, mainly trade marks and designs.
  • Austrian rules on remuneration for inventions made by employees are in several aspects quite different to those in Germany. Two of them are highlighted here.
  • The minimum requirements for securing a filing date (and priority date) of a Malaysian patent application to be issued by the Malaysian IP Office (MyIPO) are: a) the name and address of the applicant(s), b) the name and address of the inventor(s), c) a patent specification comprising a description, claims and any necessary drawings; and d) the country and filing date of any earlier application whose priority is claimed. It is preferable, although not essential, to file the following additional information and documents with the initial application; e) the serial number of any priority application and the symbol of the International Patent Classification (IPC) allocated to it (if available), f) the state of incorporation/nationality of the applicant; g) an abstract of the invention; h) an Appointment of Agent form signed by the applicant and i) if the applicant is not the inventor, a statement explaining how the applicant derives its right to the patent from the inventor(s), normally by virtue of assignment, employment or any other agreement.
  • Michael Williams and Cameron Andrews of Gilbert + Tobin explain the copyright aspects of Australian law and practice, including the options for enforcement
  • Despite the US Supreme Court’s finding that scandalous or immoral trademarks cannot be banned, lawyers say that the judgment’s impact may be limited in practice
  • The Coalition for Affordable Drugs has filed another inter partes review petition at the Patent Trial and Appeal Board, in the latest move by Kyle Bass and Erich Spangenberg to target pharmaceutical companies’ patents
  • Managing IP's first IP Enforcement Forum took place in London on October 5. Topics discussed included designs, EU trade mark reform, online counterfeits, trade secrets, trade dress, social media and the Digital Single Market
  • A concurring opinion in Nidec Motor v Zhongshan Broad Ocean Motor critical of the PTAB’s position on joinder and expanded panels suggests the Federal Circuit will further scrutinise these issues in future decisions